Literature DB >> 18337581

Generation of antiviral major histocompatibility complex class I-restricted T cells in the absence of CD8 coreceptors.

Nicolas P Andrews1, Christopher D Pack, Aron E Lukacher.   

Abstract

The CD8 coreceptor is important for positive selection of major histocompatibility complex I (MHC-I)-restricted thymocytes and in the generation of pathogen-specific T cells. However, the requirement for CD8 in these processes may not be essential. We previously showed that mice lacking beta(2)-microglobulin are highly susceptible to tumors induced by mouse polyoma virus (PyV), but CD8-deficient mice are resistant to these tumors. In this study, we show that CD8-deficient mice also control persistent PyV infection as efficiently as wild-type mice and generate a substantial virus-specific, MHC-I-restricted, T-cell response. Infection with vesicular stomatitis virus (VSV), which is acutely cleared, also recruited antigen-specific, MHC-I-restricted T cells in CD8-deficient mice. Yet, unlike in VSV infection, the antiviral MHC-I-restricted T-cell response to PyV has a prolonged expansion phase, indicating a requirement for persistent infection in driving T-cell inflation in CD8-deficient mice. Finally, we show that the PyV-specific, MHC-I-restricted T cells in CD8-deficient mice, while maintained long term at near-wild-type levels, are short lived in vivo and have extremely narrow T-cell receptor repertoires. These findings provide a possible explanation for the resistance of CD8-deficient mice to PyV-induced tumors and have implications for the maintenance of virus-specific MHC-I-restricted T cells during persistent infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18337581      PMCID: PMC2346753          DOI: 10.1128/JVI.02698-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  Resistance to polyoma virus-induced tumors correlates with CTL recognition of an immunodominant H-2Dk-restricted epitope in the middle T protein.

Authors:  A E Lukacher; C S Wilson
Journal:  J Immunol       Date:  1998-02-15       Impact factor: 5.422

2.  CD4-negative cytotoxic T cells with a T cell receptor alpha/beta intermediate expression in CD8-deficient mice.

Authors:  A H Dalloul; K Ngo; W P Fung-Leung
Journal:  Eur J Immunol       Date:  1996-01       Impact factor: 5.532

3.  Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection.

Authors:  K Murali-Krishna; J D Altman; M Suresh; D J Sourdive; A J Zajac; J D Miller; J Slansky; R Ahmed
Journal:  Immunity       Date:  1998-02       Impact factor: 31.745

4.  Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients.

Authors:  P P Lee; C Yee; P A Savage; L Fong; D Brockstedt; J S Weber; D Johnson; S Swetter; J Thompson; P D Greenberg; M Roederer; M M Davis
Journal:  Nat Med       Date:  1999-06       Impact factor: 53.440

5.  Late priming and variability of epitope-specific CD8+ T cell responses during a persistent virus infection.

Authors:  Christopher C Kemball; Eun D Han Lee; Vaiva Vezys; Thomas C Pearson; Christian P Larsen; Aron E Lukacher
Journal:  J Immunol       Date:  2005-06-15       Impact factor: 5.422

6.  Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers.

Authors:  C Yee; P A Savage; P P Lee; M M Davis; P D Greenberg
Journal:  J Immunol       Date:  1999-02-15       Impact factor: 5.422

7.  Beta 2-microglobulin knockout mice are highly susceptible to polyoma virus tumorigenesis.

Authors:  D R Drake; A E Lukacher
Journal:  Virology       Date:  1998-12-05       Impact factor: 3.616

8.  CD8 lineage commitment in the absence of CD8.

Authors:  A W Goldrath; K A Hogquist; M J Bevan
Journal:  Immunity       Date:  1997-05       Impact factor: 31.745

9.  Continuous recruitment of naive T cells contributes to heterogeneity of antiviral CD8 T cells during persistent infection.

Authors:  Vaiva Vezys; David Masopust; Christopher C Kemball; Daniel L Barber; Leigh A O'Mara; Christian P Larsen; Thomas C Pearson; Rafi Ahmed; Aron E Lukacher
Journal:  J Exp Med       Date:  2006-09-11       Impact factor: 14.307

10.  T cell affinity maturation by selective expansion during infection.

Authors:  D H Busch; E G Pamer
Journal:  J Exp Med       Date:  1999-02-15       Impact factor: 14.307

View more
  15 in total

1.  MHC class I family proteins retard systemic lupus erythematosus autoimmunity and B cell lymphomagenesis.

Authors:  Caroline G McPhee; Thomas J Sproule; Dong-Mi Shin; Jason A Bubier; William H Schott; Martin P Steinbuck; Lia Avenesyan; Herbert C Morse; Derry C Roopenian
Journal:  J Immunol       Date:  2011-09-30       Impact factor: 5.422

2.  Minor antigens on transfused RBCs crossprime CD8 T cells but do not induce full effector function.

Authors:  M Desmarets; G Mylvaganam; E K Waller; C D Josephson; C Pack; A E Lukacher; J C Zimring
Journal:  Am J Transplant       Date:  2011-09       Impact factor: 8.086

3.  CD8 T cells recruited early in mouse polyomavirus infection undergo exhaustion.

Authors:  Jarad J Wilson; Christopher D Pack; Eugene Lin; Elizabeth L Frost; Joshua A Albrecht; Annette Hadley; Amelia R Hofstetter; Satvir S Tevethia; Todd D Schell; Aron E Lukacher
Journal:  J Immunol       Date:  2012-03-23       Impact factor: 5.422

4.  Reply to "CD8+ T cells are essential for controlling acute friend virus infection in C57BL/6 mice".

Authors:  Sachiyo Tsuji-Kawahara; Shiki Takamura; Masaaki Miyazawa
Journal:  J Virol       Date:  2014-05       Impact factor: 5.103

5.  IL-21 can supplement suboptimal Lck-independent MAPK activation in a STAT-3-dependent manner in human CD8(+) T cells.

Authors:  Osamu Imataki; Sascha Ansén; Makito Tanaka; Marcus O Butler; Alla Berezovskaya; Matthew I Milstein; Kiyotaka Kuzushima; Lee M Nadler; Naoto Hirano
Journal:  J Immunol       Date:  2012-01-11       Impact factor: 5.422

6.  Cutting edge: shift in antigen dependence by an antiviral MHC class Ib-restricted CD8 T cell response during persistent viral infection.

Authors:  Phillip A Swanson; Amelia R Hofstetter; Jarad J Wilson; Aron E Lukacher
Journal:  J Immunol       Date:  2009-05-01       Impact factor: 5.422

7.  Pathogen Stimulation History Impacts Donor-Specific CD8(+) T Cell Susceptibility to Costimulation/Integrin Blockade-Based Therapy.

Authors:  I R Badell; W H Kitchens; M E Wagener; A E Lukacher; C P Larsen; M L Ford
Journal:  Am J Transplant       Date:  2015-07-30       Impact factor: 8.086

8.  Memory T cell-mediated rejection is mitigated by FcγRIIB expression on CD8+ T cells.

Authors:  Anna B Morris; David F Pinelli; Danya Liu; Maylene Wagener; Mandy L Ford
Journal:  Am J Transplant       Date:  2020-03-24       Impact factor: 8.086

Review 9.  Immunity to polyomavirus infection: the polyomavirus-mouse model.

Authors:  Phillip A Swanson; Aron E Lukacher; Eva Szomolanyi-Tsuda
Journal:  Semin Cancer Biol       Date:  2009-02-14       Impact factor: 15.707

10.  Duality of the murine CD8 compartment.

Authors:  Raphaël Genolet; Julie Leignadier; Magne Østerås; Laurent Farinelli; Brian J Stevenson; Immanuel F Luescher
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.